266 related articles for article (PubMed ID: 18698035)
1. Predicting clinical outcome through molecular profiling in stage III melanoma.
John T; Black MA; Toro TT; Leader D; Gedye CA; Davis ID; Guilford PJ; Cebon JS
Clin Cancer Res; 2008 Aug; 14(16):5173-80. PubMed ID: 18698035
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
3. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
[TBL] [Abstract][Full Text] [Related]
4. Melanoma gene expression and clinical course.
Vourc'h-Jourdain M; Volteau C; Nguyen JM; Khammari A; Dreno B
Arch Dermatol Res; 2009 Oct; 301(9):673-9. PubMed ID: 19326132
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
6. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
8. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.
Mian S; Ugurel S; Parkinson E; Schlenzka I; Dryden I; Lancashire L; Ball G; Creaser C; Rees R; Schadendorf D
J Clin Oncol; 2005 Aug; 23(22):5088-93. PubMed ID: 16051955
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
Winnepenninckx V; van den Oord JJ
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
[TBL] [Abstract][Full Text] [Related]
11. Gene expression signature predicts recurrence in lung adenocarcinoma.
Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
[TBL] [Abstract][Full Text] [Related]
12. Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.
Achiron A; Gurevich M; Snir Y; Segal E; Mandel M
Clin Exp Immunol; 2007 Aug; 149(2):235-42. PubMed ID: 17488294
[TBL] [Abstract][Full Text] [Related]
13. Molecular staging in stage II and III melanoma patients and its effect on long-term survival.
Voit C; Kron M; Rademaker J; Schwürzer-Voit M; Sterry W; Weber L; Ozdemir C; Proebstle T; Keilholz U
J Clin Oncol; 2005 Feb; 23(6):1218-27. PubMed ID: 15718319
[TBL] [Abstract][Full Text] [Related]
14. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
[TBL] [Abstract][Full Text] [Related]
15. Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.
Ugurel S; Schrama D; Keller G; Schadendorf D; Bröcker EB; Houben R; Zapatka M; Fink W; Kaufman HL; Becker JC
Cancer Immunol Immunother; 2008 May; 57(5):685-91. PubMed ID: 17909797
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
17. Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction.
Lewis TB; Robison JE; Bastien R; Milash B; Boucher K; Samlowski WE; Leachman SA; Dirk Noyes R; Wittwer CT; Perreard L; Bernard PS
Cancer; 2005 Oct; 104(8):1678-86. PubMed ID: 16116595
[TBL] [Abstract][Full Text] [Related]
18. Novel genes associated with malignant melanoma but not benign melanocytic lesions.
Talantov D; Mazumder A; Yu JX; Briggs T; Jiang Y; Backus J; Atkins D; Wang Y
Clin Cancer Res; 2005 Oct; 11(20):7234-42. PubMed ID: 16243793
[TBL] [Abstract][Full Text] [Related]
19. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling predicts survival in conventional renal cell carcinoma.
Zhao H; Ljungberg B; Grankvist K; Rasmuson T; Tibshirani R; Brooks JD
PLoS Med; 2006 Jan; 3(1):e13. PubMed ID: 16318415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
